A complication with medications is their secondary effect, so-called polypharmacy. Think of harnessing currently existing medications, or their combinations, for repurposing in life extension. A possible way to do this is to enable collecting and organizing grassroots trials for mTOR inhibitors (rapalogs), statins, metformin, etc., as these seem to increase lifespan and healthspan in model organisms.
Patient risks' assessment
To assess patients' risk, one could develop an open-source platform or possibly a custom software for hospitals. For example, using nomograms, one could combine several diagnostic results into an easy-to-understand 1-5 / 0-1 / 0-100 risk scale.